美国食品药品监督管理局（FDA）拟任命生物技术高管马卡里担任首席药品监管官。

Core Viewpoint - The FDA is planning to appoint biotechnology executive Macari as the Chief Drug Regulator [1] Group 1 - The appointment of Macari is expected to influence drug regulation policies and practices within the FDA [1] - Macari's background in biotechnology may bring a new perspective to the FDA's approach to drug approvals and oversight [1] - This move reflects the FDA's ongoing efforts to enhance its regulatory framework in response to the evolving pharmaceutical landscape [1]